Patent · US Active

Method of the invention preparations of factor IXa

US7767647B2 · kind B2 · utility

0Cited by
16References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 30, 2008
Grant dateAug 3, 2010
Priority date
Expiry dateJul 30, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of treating bleeding disorders in a subject by administration of a preparation enriched for Factor IXa. The Factor IXa can be produced by proteolytically activating recombinantly-produced Factor IX. The invention also provides an improved method for producing Factor IXa from a plasma fraction, which method results in a Factor IXa product containing little or no prekallikrein activity, thus reducing the incidence of undesired side effects in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.